Loading...
Long‐term efficacy of eculizumab in refractory generalized myasthenia gravis: responder analyses
OBJECTIVE: Generalized myasthenia gravis (gMG) is an autoimmune disease that causes disabling weakness via damage to the neuromuscular junction. In most patients, the disease is mediated by autoantibodies to the acetylcholine receptor, which activate the complement cascade. Our objective was to anal...
Na minha lista:
| Udgivet i: | Ann Clin Transl Neurol |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8283175/ https://ncbi.nlm.nih.gov/pubmed/34043280 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.51376 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|